Today, the Minnesota Legislature passed HF 3100, the Alec Smith Insulin Affordability Act. This bill requires manufacturers to provide insulin at no cost to individuals or pharmacies for emergency access and has increased penalties on those manufacturers who fail to comply. In response to the passage of HF 3100, Senators Melissa Halvorson Wiklund, John Marty, and Matt Little released the following statement.
The Minnesota Senate passed HF 3100 Thursday, a bill establishing an emergency insulin access program. In response to the passage of the bill, Senator Matt Little (DFL-Lakeville) released the following statement.
To help Minnesota farmers facing difficult economic situations and operating on razor-thin margins, Senator Matt Little (DFL-Lakeville) presented legislation that would exempt grain bins from Minnesota sales taxes.
Senator Matt Little presented a bill in the Senate Commerce and Consumer Protection Finance and Policy Committee on Tuesday that would require health plan companies to disclose the brand(s) of insulin and equipment and supplies they cover, and prohibits the removal from coverage of any particular brand of insulin, equipment, or supplies described during an enrollee’s contract year.
n preparation for a bonding bill-focused legislative session, Senator Matt Little (DFL-Lakeville) organized a Senate District 58 bonding tour Monday to meet with local leaders and tour several locations and projects that will be seeking state funding in the 2020 session.
Bipartisan Insulin Deal Reached: Sen. Little Convenes Negotiations Among DFL and GOP House, Senate Members
“It’s far from perfect, but this deal will save lives,” Sen. Matt Little (D-Lakeville) commented while announcing a bipartisan framework to provide emergency insulin supplies to patients in extreme need, “And every day we fail to act, another young person might die without emergency access to insulin. All we’ve got left is to hammer out the funding mechanism and we could pass this in a special session.”